Daytime polysomnography to perform titration for upper airway stimulation in patients with obstructive sleep apnea

Autor: Pien F. N. Bosschieter, Nico de Vries, Emily Schoustra, Madeline J. L. Ravesloot, Meerie J L Steinbusch, Kristel M Kasius
Přispěvatelé: Oral Kinesiology
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Bosschieter, P F N, Schoustra, E, de Vries, N, Steinbusch, M J L, Kasius, K M & Ravesloot, M J L 2021, ' Daytime polysomnography to perform titration for upper airway stimulation in patients with obstructive sleep apnea ', Sleep and Breathing, vol. 26, no. 2, pp. 707-715 . https://doi.org/10.1007/s11325-021-02441-w
Sleep & Breathing = Schlaf & Atmung
Sleep and breathing
Sleep and Breathing, 26(2), 707-715. Springer Verlag
ISSN: 1522-1709
1520-9512
DOI: 10.1007/s11325-021-02441-w
Popis: © 2021, The Author(s), under exclusive licence to Springer Nature Switzerland AG.Purpose: Upper airway stimulation (UAS) is an innovative treatment for patients with obstructive sleep apnea (OSA). UAS titrations are performed 3 months after activation of the device to optimize its effectiveness. In general, these titrations are performed during an in-laboratory overnight polysomnography (PSG). However, overnight titrations are expensive and can be logistically challenging because they are labor-intensive which causes shortage of sleep technicians available for night shifts. In addition, recently, overnight PSGs were postponed and canceled due to the COVID-19 pandemic. We aimed to assess the feasibility of a daytime PSG to perform titration of UAS therapy as an alternative for a conventional overnight PSG. Methods: We performed a prospective single-center observational cohort study. Patients were included when planned for UAS titration; this was approximately 6 months after UAS activation. Data on sleep architecture, patient experience, and respiratory outcomes were collected to evaluate the feasibility. An overnight follow-up PSG 12 months after implantation was used to compare sleep architecture and therapy response. Results: Of 23 patients, four were excluded from analysis because of technical issues during PSG. Even though patients slept significantly shorter during the daytime PSG, this was enough time to complete the titration successfully with 30-min sleep in final therapeutic settings in 84% of the patients. Patients (94%) had a positive experience with the daytime titration. Respiratory outcomes were significantly reduced during titration and were maintained at the 12-month follow-up. Conclusion: Daytime titrations are a valuable alternative for conventional overnight titrations. Our findings suggest the implementation of daytime titrations as standard of care. This will contribute to easier logistics and better work circumstances for sleep technicians without jeopardizing titration quality.
Databáze: OpenAIRE
Externí odkaz: